Question

A 64-year-old woman with HFrEF (LVEF 30%), NYHA II, on ARNI and beta-blocker. Which additional class improves morbidity and mortality irrespective of diabetes?

Accepted Answer

SGLT2 inhibitor (e.g., dapagliflozin)

Answer

Long-acting nitrate monotherapy

Answer

Verapamil

Answer

Ivabradine as first add-on

Answer

Aldosterone antagonist only if diabetes present

Practice question

A 64-year-old woman with HFrEF (LVEF 30%), NYHA II, on ARNI and beta-blocker. Which additional class improves morbidity and mortality irrespective of diabetes?